Skip to main content

Day: August 5, 2020

BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China

Phase 1 study will evaluate safety and immunogenicity in Chinese participants to support potential regulatory approval pathway in ChinaTotal of 144 participants to be enrolled in two age groups (18-55 and >55 years)Trial participants to receive either 10µg or 30µg of BNT162 or a placeboClinical supply from BioNTech’s GMP-certified mRNA production facilities in EuropeMAINZ, Germany, and SHANGHAI, China, Aug. 05, 2020 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma” or “Group”; Stock Symbol: 600196.SH, 02196.HK), today announced that the first 72 participants have already been dosed with BNT162b1 following IND approval by the Chinese regulatory authority, National Medical Products Administration (NMPA). BioNTech and Fosun Pharma are jointly...

Continue reading

BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem COVID-19-Impfstoffkandidaten in China

Phase-1-Studie wird Sicherheit und Immunogenität in chinesischen Probanden evaluieren, um eine potenzielle Zulassung in China zu unterstützenInsgesamt werden 144 Probanden in zwei Altersgruppen in die Studie eingeschlossen (18-55 und >55 Jahre)Probanden erhalten entweder 10 µg oder 30 µg BNT162 oder PlaceboMaterial für klinische Studie wird von BioNTechs GMP-zertifizierten mRNA-Produktionsstätten in Europa bereitgestellt             MAINZ, Deutschland, und SHANGHAI, China, Aug. 05, 2020 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) und Shanghai Fosun Pharmaceutical (Group) Co., Ltd („Fosun Pharma“ oder „die Gruppe“; Börsensymbol: 600196.SH, 02196.HK) gaben heute bekannt, dass die ersten 72 Probanden mit BNT162b1 geimpft wurden, nachdem die chinesische Behörde National Medical Products Administration...

Continue reading

Alm. Brand A/S – Annual General Meeting 28 August 2020

5 August 2020Announcement no. 33/2020Alm. Brand A/S – Annual General Meeting 28 August 2020With reference to the information obligations for issuers of listed securities on Nasdaq Copenhagen A/S we attach the notice and the agenda of the annual general meeting and the complete proposals for the annual general meeting to be held on 28 August 2020.ContactPlease direct any questions regarding this announcement to:Senior Vice President, Investor RelationsLars HolmMobile no. +45 2510 4717Senior Investor Relations Officer                                                                               Mikael Bo Larsen                                                                                                             Mobile no. +45 5143 8002      AttachmentsAS 33 2020 – Notice of annual general meetingNotice of annual general meetingAgenda...

Continue reading

Alm. Brand A/S – Ordinær generalforsamling den 28. august 2020

5. august 2020Selskabsmeddelelse nr. 33/2020Alm. Brand A/S – Ordinær generalforsamling den 28. august 2020Med henvisning til oplysningsforpligtelserne for udstedere af børsnoterede værdipapirer på Nasdaq Copenhagen A/S fremsendes vedhæftet indkaldelse samt dagsorden og de fuldstændige forslag til den ordinære generalforsamling i Alm. Brand A/S den 28. august 2020.        KontaktEventuelle henvendelser vedrørende denne selskabsmeddelelse bedes rettet til:Direktør for Investor RelationsLars Holmmobil nr. 25 10 47 17Senior Investor Relations Officer                                                                               Mikael Bo Larsen                                                                                                             mobil nr. 51 43 80 02               Vedhæftede filerAS 33 2020 – Indkaldelse til generalforsamlingAktionærbrevDagsorden...

Continue reading

Release date of six-month interim report (Q2) 2020 for ALK and audio cast

On Wednesday, 12 August 2020, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its six-month interim report (Q2) 2020.ALK will host a meeting for analysts and institutional investors that day at 1.30 p.m. (CEST) at which Management will review the financial results, the outlook and answer questions.The meeting will be audio cast live on our website https://ir.alk.net, where the related presentation will be available shortly before the meeting begins.Participants in the conference call are kindly requested to call in before 1.25 p.m. (CEST). Danish participants should call in on tel. +45 3544 5577 and international participants should call in on tel. +44 333 300 0804 or +1 631 913 1422. Please use the Participant Pin Code: 73006317#.ALK-Abelló A/SFor further information please contact:Investor Relations: Per Plotnikof, tel. +45 4574...

Continue reading

Dato for offentliggørelse af delårsrapport for første halvår (Q2) 2020 for ALK og webcast

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør delårsrapport for første halvår (Q2) 2020 onsdag den 12. august 2020.ALK afholder samme dag kl. 13.30 (CEST) en telefonkonference for investorer og analytikere, hvor ledelsen fremlægger resultater og forventninger samt besvarer spørgsmål.Mødet audiocastes på https://ir.alk.net, hvor den tilhørende præsentation vil være tilgængelig kort før start.Deltagere i telefonkonferencen bedes ringe ind senest kl. 13.25 (CEST). Danske deltagere skal ringe på tlf. 3544 5577, mens internationale deltagere skal ringe på +44 333 300 0804 eller+1 631 913 1422. Benyt venligst følgende deltager-pinkode: 73006317#ALK-Abelló A/SFor yderligere oplysninger kontakt venligst:Investor Relations: Per Plotnikof, tlf. 4574 7527, mobil 2261 2525Presse: Jeppe Ilkjær, mobil 3050 2014Om ALKALK er en global, specialiseret...

Continue reading

CPH adapts organisation to prolonged period with fewer passengers

In order to secure its long-term competitive strength, Copenhagen Airports (CPH) will align its organisation to the lower level of activity which the aviation industry is currently experiencing as a result of the coronavirus crisis and which is expected to continue for some time. As a result, CPH is contemplating cutting 650 full-time positions from the company’s current approximate total of 2,600. Over the coming weeks, discussions will be held with CPH’s union representatives to determine the expected redundancies. Copenhagen Airport CEO Thomas Woldbye says this is the saddest decision he has had to make during his nine years with CPH, but that it is necessary in order to safeguard the airport’s future operations and financial position.Although several countries have begun to reopen and allow travel, it has become clear that 2020 will...

Continue reading

CPH tilpasser organisationen til længere periode med færre passagerer

For at sikre den langsigtede konkurrenceevne vil Københavns Lufthavne (CPH) tilpasse sin organisation til det lavere aktivitetsniveau, som er en konsekvens af coronakrisen i luftfarten nu og i den kommende tid. Det betyder bl.a., at CPH påtænker at nedlægge 650 fuldtidsstillinger (FTE) ud af virksomhedens cirka 2600. Over de kommende uger vil der være drøftelser med CPHs tillidsrepræsentanter om udmøntningen af de forventede afskedigelser. Administrerende direktør Thomas Woldbye kalder beslutningen for den mest triste i sine ni år i lufthavnen – men også nødvendig for at fremtidssikre lufthavnens økonomi og drift.Selv om flere lande er begyndt at åbne for grænserne og tillade rejser, står det klart, at 2020 vil blive et år med markant færre flyrejser. Både erhvervs- som ferierejser forventes at ligge væsentligt under tidligere års niveau...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.